British drugmaker Advanz Pharma has attracted interest from several PE bidders including The Carlyle Group, Nordic Capital and TDR, according to Reuters. The company has already received indicative offers. Advanz's creditors, who are hoping to fetch $2 billion, have been seeking new owners for the business since it went through a debt restructuring last year. The auction is being led by investment bank Jefferies.